Role of LXRs in control of lipogenesis

Joshua R. Schultz, Hua Tu, Alvin Luk, Joyce J. Repa, Julio C. Medina, Leping Li, Susan Schwendner, Shelley Wang, Martin Thoolen, David J. Mangelsdorf, Kevin D. Lustig, Bei Shan

Research output: Contribution to journalArticle

1207 Citations (Scopus)

Abstract

The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metabolism. The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR. Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species. Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.

Original languageEnglish (US)
Pages (from-to)2831-2838
Number of pages8
JournalGenes and Development
Volume14
Issue number22
DOIs
StatePublished - Nov 15 2000

Fingerprint

Lipogenesis
Sterol Regulatory Element Binding Protein 1
Gene Targeting
Cricetinae
Oral Administration
Liver X Receptors
Phospholipids
Triglycerides
Fatty Acids
Cell Culture Techniques
Cholesterol
Ligands
Lipids
Genes

Keywords

  • Fatty acid
  • Lipogenesis
  • LXR
  • SREBP
  • Triglyceride

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., ... Shan, B. (2000). Role of LXRs in control of lipogenesis. Genes and Development, 14(22), 2831-2838. https://doi.org/10.1101/gad.850400

Role of LXRs in control of lipogenesis. / Schultz, Joshua R.; Tu, Hua; Luk, Alvin; Repa, Joyce J.; Medina, Julio C.; Li, Leping; Schwendner, Susan; Wang, Shelley; Thoolen, Martin; Mangelsdorf, David J.; Lustig, Kevin D.; Shan, Bei.

In: Genes and Development, Vol. 14, No. 22, 15.11.2000, p. 2831-2838.

Research output: Contribution to journalArticle

Schultz, JR, Tu, H, Luk, A, Repa, JJ, Medina, JC, Li, L, Schwendner, S, Wang, S, Thoolen, M, Mangelsdorf, DJ, Lustig, KD & Shan, B 2000, 'Role of LXRs in control of lipogenesis', Genes and Development, vol. 14, no. 22, pp. 2831-2838. https://doi.org/10.1101/gad.850400
Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L et al. Role of LXRs in control of lipogenesis. Genes and Development. 2000 Nov 15;14(22):2831-2838. https://doi.org/10.1101/gad.850400
Schultz, Joshua R. ; Tu, Hua ; Luk, Alvin ; Repa, Joyce J. ; Medina, Julio C. ; Li, Leping ; Schwendner, Susan ; Wang, Shelley ; Thoolen, Martin ; Mangelsdorf, David J. ; Lustig, Kevin D. ; Shan, Bei. / Role of LXRs in control of lipogenesis. In: Genes and Development. 2000 ; Vol. 14, No. 22. pp. 2831-2838.
@article{fd369291be8e455f961b4d161f94c251,
title = "Role of LXRs in control of lipogenesis",
abstract = "The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metabolism. The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR. Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species. Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.",
keywords = "Fatty acid, Lipogenesis, LXR, SREBP, Triglyceride",
author = "Schultz, {Joshua R.} and Hua Tu and Alvin Luk and Repa, {Joyce J.} and Medina, {Julio C.} and Leping Li and Susan Schwendner and Shelley Wang and Martin Thoolen and Mangelsdorf, {David J.} and Lustig, {Kevin D.} and Bei Shan",
year = "2000",
month = "11",
day = "15",
doi = "10.1101/gad.850400",
language = "English (US)",
volume = "14",
pages = "2831--2838",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "22",

}

TY - JOUR

T1 - Role of LXRs in control of lipogenesis

AU - Schultz, Joshua R.

AU - Tu, Hua

AU - Luk, Alvin

AU - Repa, Joyce J.

AU - Medina, Julio C.

AU - Li, Leping

AU - Schwendner, Susan

AU - Wang, Shelley

AU - Thoolen, Martin

AU - Mangelsdorf, David J.

AU - Lustig, Kevin D.

AU - Shan, Bei

PY - 2000/11/15

Y1 - 2000/11/15

N2 - The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metabolism. The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR. Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species. Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.

AB - The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol metabolism. The identification here of a synthetic, nonsteroidal LXR-selective agonist series represented by T0314407 and T0901317 revealed a novel physiological role of LXR. Oral administration of T0901317 to mice and hamsters showed that LXR activated the coordinate expression of major fatty acid biosynthetic genes (lipogenesis) and increased plasma triglyceride and phospholipid levels in both species. Complementary studies in cell culture and animals suggested that the increase in plasma lipids occurs via LXR-mediated induction of the sterol regulatory element-binding protein 1 (SREBP-1) lipogenic program.

KW - Fatty acid

KW - Lipogenesis

KW - LXR

KW - SREBP

KW - Triglyceride

UR - http://www.scopus.com/inward/record.url?scp=0034669171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034669171&partnerID=8YFLogxK

U2 - 10.1101/gad.850400

DO - 10.1101/gad.850400

M3 - Article

VL - 14

SP - 2831

EP - 2838

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 22

ER -